Skip to main content

Table 3 Survival rates of incident patients with ESKD (mean percentage and 95% confidence interval [CI])

From: Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963–2014)

PKD

0.5 years

1 year

3 years

5 years

 1963–1974

90.7 [85.3–94.2]

82.0 [75.4–87.0]

64.0 [56.3–70.6]

52.3 [44.6–59.5]

 1975–1984

97.0 [95.1–98.2]

92.9 [90.3–94.8]

76.7 [72.8–80.2]

65.5 [61.2–69.4]

 1985–1994

97.0 [95.6–97.9]

94.3 [92.5–95.7]

82.9 [80.2–85.3]

72.1 [69.0–75.0]

 1995–2004

98.3 [97.4–98.9]

96.1 [94.9–97.1]

85.8 [83.8–87.6]

77.7 [75.3–79.9]

 2005–2014

98.5 [97.8–99.0]

97.1 [96.2–97.8]

91.2 [89.6–92.5]

85.1 [83.1–86.9]

Non-PKD

 Total

  1963–1974

88.1 [86.7–89.4]

79.6 [77.9–81.3]

61.5 [59.5–63.5]

52.4 [50.3–54.5]

  1975–1984

93.3 [92.6–93.9]

86.6 [85.7–87.5]

69.9 [68.7–71.1]

58.9 [57.6–60.1]

  1985–1994

94.6 [94.2–95.0]

89.2 [88.6–89.8]

68.7 [67.7–69.5]

54.4 [53.5–55.4]

  1995–2004

93.8 [93.5–94.1]

87.6 [87.1–88.1]

66.5 [65.9–67.2]

51.1 [50.4–51.8]

  2005–2014

94.0 [93.7–94.3]

89.1 [88.7–89.4]

70.4 [69.8–71.0]

55.2 [55.5–56.0]

 Diabetic/Vascular

  1963–1974

79.9 [73.4–84.9]

68.8 [61.7–74.9]

43.4 [36.3–50.3]

38.1 [31.2–45.0]

  1975–1984

87.0 [84.4–89.1]

76.4 [73.3–79.2]

50.3 [46.8–53.8]

35.6 [32.3–39.0]

  1985–1994

92.1 [91.0–93.6]

84.0 [83.6–85.4]

52.6 [50.6–54.4]

33.3 [31.4–35.0]

  1995–2004

92.7 [92.2–93.3]

85.1 [84.3–85.8]

58.0 [56.9–59.0]

38.0 [36.9–39.0]

  2005–2014

94.0 [93.6–94.3]

88.3 [87.8–88.8]

65.6 [64.7–66.4]

46.6 [45.6–47.6]

 Non-vascular

  1963–1974

88.9 [87.5–90.2]

80.7 [78.9–82.3]

63.3 [61.1–65.3]

53.8 [51.6–55.9]

  1975–1984

94.3 [93.6–94.9]

88.3 [87.3–89.1]

73.1 [71.8–74.3]

62.6 [61.3–64.0]

  1985–1994

95.5 [95.0–95.9]

91.0 [90.3–91.6]

74.2 [73.2–75.2]

61.9 [60.8–63.0]

  1995–2004

94.6 [94.2–95.0]

89.5 [88.9–90.0]

72.9 [72.0–73.7]

60.8 [59.9–61.7]

  2005–2014

94.0 [93.6–94.4]

90.0 [89.4–90.4]

75.8 [74.9–76.6]

65.7 [63.7–65.7]

  1. Note: Non-PKD group shown as “Total” or sub-divided into “Vascular/Diabetes” and “Non-vascular”